Concern has emerged that ACE inhibitors and angiotensin-receptor blockers (ARBs), which are commonly used to control hypertension, could increase the risk for SARS-CoV-2 infection because in some studies these drugs increased the expression of ACE2, the entry receptor for SARS-CoV-2, in the heart and kidney [214]. This evidence concerns the gene ACE2 and hypertensive disorder.